Search Results - "SHRAM, Megan J"
-
1
Assessment of the physical dependence potential of difelikefalin: Randomized placebo-controlled study in patients receiving hemodialysis
Published in Clinical and translational science (01-09-2023)“…Difelikefalin is a selective kappa opioid receptor agonist approved for treating moderate-to-severe pruritus in adults undergoing hemodialysis (HD)…”
Get full text
Journal Article -
2
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
Published in Translational psychiatry (07-06-2023)“…Esmethadone (REL-1017) is the opioid-inactive dextro-isomer of methadone and a low-affinity, low-potency uncompetitive NMDA receptor antagonist. In a Phase 2,…”
Get full text
Journal Article -
3
Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users
Published in Clinical and translational science (01-02-2022)“…Difelikefalin, a selective kappa‐opioid receptor agonist with limited central nervous system penetration, is being developed for the treatment of chronic…”
Get full text
Journal Article -
4
Sex differences in yohimbine-induced increases in the reinforcing efficacy of nicotine in adolescent rats
Published in Addiction biology (01-03-2014)“…Stress is an important factor in the initiation and maintenance of smoking in adolescents. Women are more vulnerable to the development of addiction to smoking…”
Get full text
Journal Article -
5
Adolescent male Wistar rats are more responsive than adult rats to the conditioned rewarding effects of intravenously administered nicotine in the place conditioning procedure
Published in Behavioural brain research (20-01-2010)“…The initiation of smoking typically begins during adolescence, suggesting that nicotine may have different motivational effects during this developmental stage…”
Get full text
Journal Article -
6
Differences in the In Vitro and In Vivo Pharmacokinetic Profiles of Once-Daily Modified-Release Methylphenidate Formulations in Canada: Examination of Current Bioequivalence Criteria
Published in Clinical therapeutics (01-05-2012)“…Abstract Background Current Canadian bioequivalence criteria rely on rate and extent of drug exposure, that is, Cmax and AUC. In the case of complex…”
Get full text
Journal Article -
7
Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist
Published in Journal of clinical psychopharmacology (01-06-2015)“…A novel clinical study design was used to evaluate the blockade of a selective short-acting μ-opioid agonist (remifentanil) in 24 opioid-experienced subjects…”
Get full text
Journal Article -
8
Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate
Published in Current medical research and opinion (03-07-2022)“…Serdexmethylphenidate (SDX) chloride (Cl) is a novel prodrug of d-methylphenidate (d-MPH). These studies evaluated the abuse potential of SDX Cl when…”
Get full text
Journal Article -
9
Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users
Published in Journal of clinical psychopharmacology (01-08-2015)“…Cocaine dependence presents a major public health issue, and to date, no pharmacotherapies are approved for its treatment. TV-1380 is a novel recombinant…”
Get full text
Journal Article -
10
Identification of Optimal Measures of Human Abuse Potential: A Post Hoc Assessment of 19 Studies
Published in Journal of clinical psychopharmacology (01-11-2020)“…Human abuse potential studies include multiple measures to assess the subjective effects of central nervous system-active drugs. In this retrospective…”
Get full text
Journal Article -
11
Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users
Published in Journal of clinical pharmacology (01-04-2014)“…The objective of this study was to evaluate abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered, crushed reformulated…”
Get full text
Journal Article -
12
Interaction of Ethanol and Oral ANS‐6637, a Selective ALDH2 Inhibitor in Males: A Randomized, Double‐Blind, Placebo‐Controlled, Single‐Ascending Dose Cohort Study
Published in Alcoholism, clinical and experimental research (01-09-2020)“…Background ANS‐6637, an orally bioavailable selective and reversible aldehyde dehydrogenase‐2 (ALDH2) inhibitor, is under development for drug and alcohol use…”
Get full text
Journal Article -
13
Nicotine Self-Administration, Extinction Responding and Reinstatement in Adolescent and Adult Male Rats: Evidence Against a Biological Vulnerability to Nicotine Addiction during Adolescence
Published in Neuropsychopharmacology (New York, N.Y.) (01-03-2008)“…Initiation of smoking behavior typically occurs during adolescence and rarely occurs during adulthood. Despite this epidemiological evidence, relatively little…”
Get full text
Journal Article -
14
Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine
Published in Psychopharmacologia (01-06-2006)“…Initiation of tobacco use typically begins during adolescence, and the nature of these first experiences with nicotine may affect the probability of continued…”
Get full text
Journal Article -
15
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial
Published in Journal of clinical pharmacology (01-02-2019)“…Buprenorphine/samidorphan combination (BUP/SAM) is an opioid system modulator being investigated as adjunctive treatment for major depressive disorder. BUP/SAM…”
Get full text
Journal Article -
16
Effects of stressors on the reinforcing efficacy of nicotine in adolescent and adult rats
Published in Psychopharmacology (01-04-2014)“…Rationale and objectives Stress increases drug intake. This depends on the stressor, drug, and aspect of drug seeking assessed. The objectives of these…”
Get full text
Journal Article -
17
Evaluation of the Abuse Potential of Extended Release Hydromorphone Versus Immediate Release Hydromorphone
Published in Journal of clinical psychopharmacology (01-02-2010)“…Immediate release (IR) hydromorphone has experienced significant misuse and abuse. An extended release (ER) hydromorphone formulation has been developed to…”
Get full text
Journal Article -
18
Age differences in the spontaneous acquisition of nicotine self-administration in male Wistar and Long–Evans rats
Published in Psychopharmacologia (01-03-2008)“…Rationale Epidemiological evidence suggests that adolescents may exhibit a unique susceptibility to the motivational effects of nicotine compared to adults. In…”
Get full text
Journal Article -
19
Acute nicotine enhances c-fos mRNA expression differentially in reward-related substrates of adolescent and adult rat brain
Published in Neuroscience letters (18-05-2007)“…A number of studies have demonstrated that adolescent rodents are more sensitive to the rewarding effects of nicotine compared to adults. To help determine the…”
Get full text
Journal Article -
20
Pharmacokinetic and Pharmacodynamic Correlations From 2 Studies Evaluating Abuse Potential of Hydrocodone Extended‐Release Tablets
Published in Clinical pharmacology in drug development (01-01-2019)“…Pharmacokinetic (PK)/pharmacodynamic (PD) correlations were explored in 2 human abuse potential studies of orally and intranasally administered hydrocodone…”
Get full text
Journal Article